Technical Analysis:
Wait the end of the price retracement before buying
Fundamental News
Inovio Pharmaceuticals (NASDAQ:INO) is a late-stage biotechnology company focused on the discovery, development, and commercialization of synthetic DNA immunotherapies and vaccines for treating cancers and infectious diseases.
Inovio's stock is up about a whopping 220% year-to-date. It is widely considered to be one of the front-runners among companies developing a COVID-19 vaccine
Wait the end of the price retracement before buying
Fundamental News
Inovio Pharmaceuticals (NASDAQ:INO) is a late-stage biotechnology company focused on the discovery, development, and commercialization of synthetic DNA immunotherapies and vaccines for treating cancers and infectious diseases.
Inovio's stock is up about a whopping 220% year-to-date. It is widely considered to be one of the front-runners among companies developing a COVID-19 vaccine